Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026
New launches in high-content imaging, detection, and automation help labs accelerate drug discovery workflows from sample to insight
New launches in high-content imaging, detection, and automation help labs accelerate drug discovery workflows from sample to insight
The DynamicOrgan O₂ Sensor Kit enables continuous, non-invasive monitoring of oxygen levels for human-relevant disease and drug models
This partnership aims to enable faster, more reliable respiratory testing outside traditional lab settings without the need for instruments or extended sample preparation
First U.S. commercial agreement delivers next-generation technology for faster, more accurate diagnostics
Expansion accelerates the development of its non-invasive cancer diagnostic solutions
The Invitrogen™ TaqMan™ Cells-to-CT™ HepatoExpress Kit lets researchers measure gene activity in liver cells without doing RNA purification, so they can go from sample to results in about 75 minutes, with only 10 minutes of hands-on work
From sample limitations to isomeric separations, see how the right column choice transformed a challenging lipidomics project
See how Nautilus Biotechnology’s Iterative Mapping platform combines ultra-sensitive protein analysis and AI-driven insights for deeper biological understanding
The ECL Series works with the HPR-40 DEMS to support both fundamental and applied electrochemistry across a wide range of research areas
From AI to aging science, experts share their predictions on the technologies and discoveries set to shape life sciences in 2026
Every biomarker in Aliri’s study-ready panels is carefully selected and rigorously verified for its intended biological context
Expansion of iXCells’ iPSCore platform with integration of 3D human organoid expertise will enable evaluation of drug toxicity and tissue-specific responses
Guest editorial from Dr. Matt Westfall, Senior Director of Biochemical Pharmacology and Proteomics at Inotiv
testo Saveris 1 provides automated and efficient support in complying with regulatory requirements
Agreement with Illumina brings industry-leading sequencing platforms together with Devyser’s validated genetic testing solutions
Offers reliable, compliant, and accessible solutions to advance scientific discovery and product development
Offering sample audit traceability, and sample tracking and data sharing between multiple users, labs and locations, tri-coded sample tubes provide a lifelong and secure chain of custody